MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
69.01
-0.08
-0.12%
After Hours: 69.25 +0.24 +0.35% 19:03 08/07 EDT
OPEN
69.03
PREV CLOSE
69.09
HIGH
70.96
LOW
67.98
VOLUME
780.57K
TURNOVER
--
52 WEEK HIGH
77.00
52 WEEK LOW
52.50
MARKET CAP
1.49B
P/E (TTM)
-54.3600
1D
5D
1M
3M
1Y
5Y
1D
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
NASDAQ · 13h ago
ANI Pharmaceuticals Q2 2025 Earnings Preview
Seeking Alpha · 19h ago
Earnings Preview For ANI Pharmaceuticals
Benzinga · 20h ago
ANI Pharmaceuticals Inc <ANIP.OQ> expected to post earnings of $1.42 a share - Earnings Preview
Reuters · 1d ago
Weekly Report: what happened at ANIP last week (0728-0801)?
Weekly Report · 3d ago
Positive Outlook on ANI Pharmaceuticals Despite Legal Setback: Buy Rating Reaffirmed
TipRanks · 07/31 09:18
Truist Financial Reaffirms Their Hold Rating on ANI Pharmaceuticals (ANIP)
TipRanks · 07/30 11:58
*ANI Pharmaceuticals Expects to Challenge Verdict
Dow Jones · 07/29 21:46
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel, ILUVIEN and YUTIQ. In addition, the Brands reporting unit includes a portfolio of over 16 brand products that are principally sold in genericized markets. Its Generics and Other segment consist of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.